Effects of exogenous hyperglucagonemia in insulin-treated diabetics.
D000328:Adult; D000941:Antigens; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D016883:Diabetic Ketoacidosis / Q000188:drug therapy; D005260:Female; D005934:Glucagon / Q000097:blood* / Q000276:immunology / Q000494:pharmacology; D006029:Glycosuria; D006801:Humans; D007328:Insulin / Q000097:blood / Q000627:therapeutic use*; D007659:Ketones / Q000652:urine; D008875:Middle Aged; D009584:Nitrogen / Q000652:urine; D014508:Urea / Q000652:urine
D000941:Antigens; D007328:Insulin; D007659:Ketones; D014508:Urea; D005934:Glucagon; D009584:Nitrogen